Elucidating the precise pharmacological mechanism of action (MOA) of naturally happening compounds can be tough. Although Tarselli et al. (sixty) made the primary de novo synthetic pathway to conolidine and showcased that this naturally transpiring compound efficiently suppresses responses to both equally chemically induced and inflammation-derived